BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 15, 2005
View Archived Issues
FX-06 cleared to begin clinical trials
Read More
Renoprotective effects of pyridavone
Read More
Preclinical profile of a nonhormonal therapy for postmenopausal syndromes
Read More
StaphVAX reduces risk of recurrent bacteremia in hemodialysis patients
Read More
SPIRIT II study of Xience V stent completes enrollment
Read More
Orphan drug designation for Coramsine for metastatic renal cell carcinoma
Read More
Recent agreement validates Oradur technology
Read More
Altachem Pharma changes name to Quest PharmaTech
Read More
Enrollment under way in phase III Amoxicillin PULSYS trial
Read More
ARIES-1 study of ambrisentan achieves enrollment target
Read More
Shire relates Q3 developments
Read More
Anti-HBV siRNAs effectively lower HBV DNA levels in vivo
Read More
In vivo neuroprotective effects of NNZ-2566
Read More
Analgesic properties of a novel antagonistic anti-TrkA monoclonal antibody
Read More
TSP-2 gene therapy prevents TSP-1-mediated fibrogenesis in a diabetic nephropathy model
Read More
A2A receptor agonists ameliorate renal NO production in diabetic nephropathy in rats
Read More
SEW-2871: An S1P1 receptor agonist with renoprotective actions in vivo
Read More
Sildenafil improves performance in rodent models of cognitive decline
Read More
OSI completes acquisition of Eyetech
Read More
Update on the long-term safety of lanthanum carbonate in dialysis patients
Read More
NCX-4016 fails to meet primary endpoint in phase II study in PAOD patients
Read More
Good safety profile reported for single-dose ACP-104 in patients with schizophrenia
Read More
Trinam reported safe in hemodialysis patients
Read More
Promising results with Oxxon's specific prime/boost therapy for chronic hepatitis B
Read More
Novel antiinfective agents disclosed in recent patent literature
Read More
Agents for metabolic disorders prepared and tested
Read More
Recent Bristol-Myers Squibb patent claims compounds with potential for thrombotic disorders
Read More